1 ORGS · 11 ACTIVITIES · 1 STATES ← back to explorer ·
program type

Adaptive Platform Trials for Breast Cancer Therapies

Conducts adaptive clinical trials that evaluate investigational drug treatments and non-surgical approaches for various breast cancer subtypes, including DCIS and advanced disease, using flexible trial designs to accelerate therapy development.

what makes this distinct Focuses on platform trials (e.g., I-SPY, RECAST DCIS) that test multiple therapies simultaneously with adaptive randomization and biomarker-driven endpoints, enabling rapid evaluation and comparison of novel agents or treatment strategies within a single infrastructure.

1
organizations
11
activities
0
child clusters
1
strategies
coverage CA 1
NTEE codes
P20
organizations

1 orgs in this cluster's subtree

Every organization with primary activities in Adaptive Platform Trials for Breast Cancer Therapies or any of its descendants. Click a column header to sort. Filter by name or state above the table.

showing 1 of 1
#OrganizationStateRevenueActivities ↓
1QUANTUM LEAP HEALTHCARE COLLABORATIVE
Quantum Leap Healthcare Collaborative is an operational research organization that designs and implements adaptive clinical trials, primarily focusing on breas…
CA$47.3M11
theories of action

strategies used in this cluster

Theories of action extracted from orgs in this subtree. Click any to see the full set of orgs running the same approach.